Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)
April 17, 2024 08:00 ET
|
Psyence Biomedical Ltd.
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that details of its upcoming Phase IIb clinical trial of...
Zapata AI Announces Significant Commercial Expansion with Andretti Global
April 17, 2024 08:00 ET
|
Zapata Computing, Inc.
BOSTON, April 17, 2024 (GLOBE NEWSWIRE) -- Zapata AI (Nasdaq: ZPTA), the Industrial Generative AI company, today announced a $1,000,000 commercial expansion, entered into on March 28, 2024, under...
BBSI Sets First Quarter 2024 Conference Call for Wednesday, May 1, 2024, at 5:00 p.m. ET
April 17, 2024 08:00 ET
|
Barrett Business Services Inc
VANCOUVER, Wash., April 17, 2024 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions, will conduct a conference call on...
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
April 17, 2024 08:00 ET
|
Windtree Therapeutics
WARRINGTON, Pa., April 17, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage...
DMC Global Schedules First Quarter Earnings Release and Conference Call
April 17, 2024 08:00 ET
|
DMC Global Inc.
BROOMFIELD, Colo., April 17, 2024 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) will announce its 2024 first quarter financial results after the stock market closes on Thursday, May 2, 2024....
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
April 17, 2024 07:49 ET
|
Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery...
Nature’s Miracle Holding Inc. and Agrify Corporation Agree to Merge
April 17, 2024 07:30 ET
|
Agrify
Nature’s Miracle Holding Inc. and Agrify Corporation Agree to Merge
Repligen to Report First Quarter 2024 Financial Results
April 17, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024....
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
April 17, 2024 07:25 ET
|
ALTERITY THERAPEUTICS LIMITED
– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 Baseline Data Confirm Approach to Target Biomarkers for Slowing...
POET Augments Investor Outreach Efforts and Announces Management Role Change
April 17, 2024 07:12 ET
|
POET Technologies Inc.
TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic...